Clinical trial
Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer
NCT06701058 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Active MMP-8 in Oral Fluid for the Detection of Oral and Oropharyngeal Cancer
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 28, 2022
- Completion date
- September 18, 2024
- Enrollment
- 107 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
biomarker in early diagnosis, oral cancer , oral squamous cell carcinoma, oral cavity cancer, oropharyngeal cancers, periodontal diseases